Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Cumulative respiratory vaccine trials by Year
Cumulative respiratory vaccine trials (COVID-19, RSV, Flu, Combo) (trials)
Moderna Cumulative respiratory vaccine trials: 53.00 trials in FY2025, up 10.4% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cumulative respiratory vaccine trials (COVID-19, RSV, Flu, Combo) (trials) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 53.00 | +10.4% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2024 | Dec 31, 2024 | 48.00 | +14.3% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2023 | Dec 31, 2023 | 42.00 | +40.0% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2022 | Dec 31, 2022 | 30.00 | +76.5% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2021 | Dec 31, 2021 | 17.00 | +88.9% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2020 | Dec 31, 2020 | 9.00 | +125.0% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2019 | Dec 31, 2019 | 4.00 | +33.3% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2018 | Dec 31, 2018 | 3.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
Cite this data
StockData. (2026). Moderna Cumulative respiratory vaccine trials, annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-respiratory
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.